Basel Medical Group (BMGL) plans to acquire $1 billion worth of Bitcoin, structured as a share-swap arrangement, to diversify financially and fund rapid growth in Asia's healthcare markets.
This move mirrors the strategy of companies like MicroStrategy in using Bitcoin as a treasury reserve asset, potentially more valuable than their core business.
BMGL is negotiating with institutional investors for the Bitcoin acquisition, aiming to have one of the biggest Bitcoin balance sheet acquisitions in the Asia-Pacific region.
Other companies globally, like Metaplanet in Japan and Semler Scientific in the U.S., are also increasing their Bitcoin reserves, with ongoing market optimism predicting Bitcoin to reach $200,000 fueled by institutional demand.